High Tide’s German Subsidiary Remexian Pharma Achieves 7.6 Tonnes of Medical Cannabis Sales in a Quarter
High Tide’s German subsidiary Remexian Pharma reported quarterly sales of 7.6 tonnes of medical cannabis. In the rapidly expanding market following Germany’s medical cannabis legalization, exports from Canadian licensed producers (LPs) are now ramping up.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
hightideinc.com
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://hightideinc.com/high-tide-reports-record-quarterly-distribution-of-7-6-tonnes-of-medical-cannabis-through-remexian-pharma-gmbh-accelerating-german-market-leadership/